The global regenerative medicine market generated a revenue of $8,186.9 million in 2019 and it is predicted to advance at a CAGR of 16.3% between 2020 and 2030. The market is also predicted to reach a valuation of $39,012.0 million by 2030. The major factors driving the advancement of the market are the rapid technological advancements, the rising incidence of genetic and chronic diseases, and the surging population of geriatric people around the world.
Download report sample at: https://www.psmarketresearch.com/market-analysis/regenerative-medicine-market/report-sample
According to various reports, around one in every three adults all over the world suffer from various chronic health conditions. Moreover, as per the World Health Organization (WHO), nearly 17.9 million people across the world die because of cardiovascular diseases every year. Besides this, the soaring investments being made by various governments in research and development (R&D) activities in the domain of regenerative medicine are also fueling the market expansion across the world.
Depending on application, the market for regenerative medicine is divided into oncology, musculoskeletal, dental, wound care, and ocular categories. Out of these, the musculoskeletal category recorded the highest growth in the market during the last few years and this trend is predicted to continue in the coming years as well. This will be because of the rising incidence of orthopedic diseases, the surging population of geriatric people, and increasing pipeline of musculoskeletal disease treatment stem cell products across the world.
Across the globe, the regenerative medicine market registered the highest growth in North America between 2014 and 2019 and this trend is likely to continue in the forthcoming years as well. This is credited to the surging number of stem cell research institutes, the soaring healthcare expenditure, the increasing number of stem cell banks, and rapid technological advancements and innovations in biomaterial scaffolds for advancing tissue engineering in the region.
Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=regenerative-medicine-market
The most-significant companies in the global regenerative medicine market are 3M Company, Smith & Nephew plc, Integra LifeSciences Holdings Corporation, Stryker Corporation, Wright Medical Group N.V., Zimmer Biomet Holdings Inc., Amgen Inc., Novartis AG, Allergan plc, Organogenesis Holdings Inc., MiMedx Group Inc., Misonix Inc., Vericel Corporation, Takeda Pharmaceutical Company Limited, and Medtronic plc.
Market Size Breakdown by Segment
- Cell Therapy
- Stem cell therapy
- Somatic cell therapy
- Stem cell therapy
- Gene Therapy
- Tissue Engineered Products
- Wound Care
- North America
- South Korea
- Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
Browse Other Related Reports
Precision Medicine Market – In the coming years, the telemedicine category will continue to hold the largest share in the precision medicine market, based on the type of personalized medical care. The healthcare sector is quickly adopting telemedicine to widen the access to medical services and reduce the burden on the staff.
Biobanking Market – The rising incidence of chronic diseases and the surging number of research and development (R&D) activities being conducted on genome are the major factors predicted to cause the surge of the global biobanking market, from $25.8 billion to $36.8 billion from 2018 to 2024.
Company Name: P&S Intelligence
Contact Person: Abhishek
Email: Send Email
Address:Noida Sector 2